Medical device company Baisheng Biotech nets nearly 10 million yuan in angel round

Baisheng Biotech (Guangzhou) announced that it has completed an angel round of financing agreement of nearly ten million yuan, with Yanghe Investment leading the investment and Zhongda Venture Capital participating.

Baisheng Biotech (Guangzhou) announced that it has completed an angel round of financing agreement of nearly ten million yuan, with Yanghe Investment leading the investment and Zhongda Venture Capital participating.

Proceeds from the latest funding will be mainly used to promote the market development of tumor immunohistochemical products, and the research and development of subsequent product technologies.

Baisheng Biotech is a medical device manufacturer located in Nansha Industrial Park, Guangdong Province. Its core team is composed of post-doctoral, doctoral, master, and overseas pathologists.

The company was established in December 2018, and is deeply involved in the field of tumor pathology. Its monoclonal antibody reagents were approved for market launch in September 2019.

Baisheng Biotech has registered more than 200 medical products and has applied for multiple invention patents and innovative utility model patents. To date, the antibody reagents of the company have been used in more than 30 hospitals across China, and the fully automatic immunohistochemical staining instrument will be launched soon.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/06/09/medical-device-company-baisheng-biotech-nets-nearly-10-million-yuan-in-angel-round/.

Leave a Reply

Please Login to Comment